KURE holdings — KraneShares MSCI All China Health Care Index ETF

KraneShares MSCI All China Health Care Index ETF (KURE) held 63 positions with net assets of $71.2M as of June 30, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 54.1% of the fund, led by BeOne Medicines AG, INNOVENT BIOLOGICS, INC., WUXI BIOLOGICS (CAYMAN) INC..

KURE top holdings

  1. BeOne Medicines AG — 8.84% ($6.30M)
  2. INNOVENT BIOLOGICS, INC. — 8.80% ($6.27M)
  3. WUXI BIOLOGICS (CAYMAN) INC. — 7.51% ($5.35M)
  4. WuXi AppTec Co., Ltd. — 5.79% ($4.12M)
  5. Jiangsu Hengrui Pharmaceuticals Co.,Ltd — 4.59% ($3.27M)
  6. Shenzhen Mindray Bio-Medical Electronics Co Ltd — 4.27% ($3.04M)
  7. Akeso Inc — 3.72% ($2.65M)
  8. CSPC PHARMACEUTICAL GROUP LIMITED — 3.68% ($2.62M)
  9. Invesco Government & Agency Portfolio — 3.55% ($2.53M)
  10. SINO BIOPHARMACEUTICAL LIMITED — 3.39% ($2.41M)
  11. WuXi AppTec Co., Ltd. — 3.35% ($2.39M)
  12. HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED — 2.85% ($2.03M)
  13. 3SBio Inc. — 2.49% ($1.77M)
  14. YUNNAN BAIYAO GROUP CO., LTD — 2.30% ($1.64M)
  15. Shanghai United Imaging Healthcare Co., Ltd. — 2.27% ($1.62M)
  16. Aier Eye Hospital Group Co., Ltd. — 2.10% ($1.49M)
  17. Sichuan Biokin Pharmaceutical Co Ltd — 1.97% ($1.40M)
  18. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd — 1.85% ($1.32M)
  19. ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. — 1.73% ($1.24M)
  20. SINOPHARM GROUP CO. LTD. — 1.67% ($1.19M)
  21. Sichuan Kelun Pharmaceutical Co., Ltd. — 1.55% ($1.10M)
  22. Haisco Pharmaceutical Group Co., Ltd. — 1.53% ($1.09M)
  23. HUADONG MEDICINE CO., LTD — 1.36% ($969K)
  24. WuXi XDC Cayman Inc — 1.35% ($964K)
  25. Shanghai Allist Pharmaceuticals Co Ltd — 1.34% ($954K)

What are KURE's top 10 holdings?

BeOne Medicines AG (8.8%), INNOVENT BIOLOGICS, INC. (8.8%), WUXI BIOLOGICS (CAYMAN) INC. (7.5%), WuXi AppTec Co., Ltd. (5.8%), Jiangsu Hengrui Pharmaceuticals Co.,Ltd (4.6%), Shenzhen Mindray Bio-Medical Electronics Co Ltd (4.3%), Akeso Inc (3.7%), CSPC PHARMACEUTICAL GROUP LIMITED (3.7%), Invesco Government & Agency Portfolio (3.5%), SINO BIOPHARMACEUTICAL LIMITED (3.4%).

How many stocks are in KURE?

KraneShares MSCI All China Health Care Index ETF reported 63 holdings as of June 30, 2026.

All ETF and mutual fund holdings